In one paragraphArticle in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Jiaqi YangDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.ORCID 0000-0003-4083-4993 Lauren BernardWelch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0001-5747-3747 Jingsha ChenDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Valerie K SullivanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.ORCID 0000-0002-2321-0188 Bing YuDepartment of Epidemiology and Human Genetics Center, University of Texas Health Science Center at Houston School of Public Health, Houston, Texas.ORCID 0000-0003-4818-1077 Eugene P RheeDivision of Nephrology and Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-4797-3200 Paul A WellingDivision of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0002-0719-8705 Casey M RebholzDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.ORCID 0000-0002-5442-8745 Funding
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.375N92022D00001 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID · 2022 to 2025
$13.7MWNK-SPAK signaling in the Distal NephronR01DK093501 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric J Delpire, Paul A Welling · 2012 to 2026
$12.1MMolecular of ROMK Channel FunctionR01DK054231 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI Paul A Welling · 1998 to 2026
$7.7MOXGR1 in Renal Intercalated Cells, Salt Transport and Diuretic EfficacyR01DK110375 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric J Delpire, SUSAN MARIE WALL · 2017 to 2026
$6.7MTHE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00003 · NHLBI · UNIVERSITY OF MINNESOTA · PI LUTSEY, PAMELA · 2022 to 2025
$5.1MTHE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00005 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WAGENKNECHT, LYNNE E · 2022 to 2025
$5.0MTHE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00004 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI WINDHAM, BEVERLY GWEN · 2022 to 2025
$4.8MTHE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A75N92022D00002 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ARGANI, PEDRAM · 2022 to 2025
$4.7MResource Development CoreU54DK137331 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI JOSEF CORESH · 2023 to 2026
$4.3MGenetic Architecture of Cardiac Structure and Function and Its Impact on Heart FailureR01HL160793 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI RAMACHANDRAN, VASAN, YU, BING · 2022 to 2025
$3.2MDiscovery, Replication, and Validation of Biomarkers of the DASH Diet and HypertensionR01HL153178 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI REBHOLZ, CASEY MARIE · 2021 to 2024
$3.1MMolecular Determinants of Atherosclerotic Cardiovascular Disease in Multi-ethnic PopulationsR01HL168683 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Bing Yu · 2023 to 2026
$2.9MNHLBI NIH HHS 75N92022D00001NHLBI NIH HHS (75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004, 75N92022D00005NHLBI NIH HHS 75N92022D00002NHLBI NIH HHS 75N92022D00003NHLBI NIH HHS 75N92022D00004NHLBI NIH HHS 75N92022D00005NHLBI NIH HHS R01 HL153178NHLBI NIH HHS R01 HL160793NHLBI NIH HHS R01HL160793; R01HL168683; R01HL163857NHLBI NIH HHS R01 HL163857NHLBI NIH HHS R01 HL168683NIDDK NIH HHS R01 DK054231NIDDK NIH HHS R01DK054231; U54DK137331; R01DK093501; R01DK110375; R25DK139778NIDDK NIH HHS R01 DK093501NIDDK NIH HHS R01 DK110375NIDDK NIH HHS R25 DK139778NIDDK NIH HHS U54 DK137331
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
CKDproteomics
Identifiers
PMID40965986
PMCPMC12453620
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390